Increased incidence of meningococcal disease in HIV-infected individuals associated with higher case-fatality ratios in South Africa

AIDS

Volumn 24, Issue 9, 2010, Pages 1351-1360

  Cohen, Cheryl ^a,b   Singh, Elvira ^b   Wu, Henry M ^e,f   Martin, Stacey ^f   De Gouveia, Linda ^a   Klugman, Keith P ^a,c,d   Meiring, Susan ^a   Govender, Nelesh ^a,c   Von Gottberg, Anne ^a,c  

^a NATIONAL INSTITUTE FOR COMMUNICABLE DISEASES   (South Africa)

^b Department of Computational Medicine and Bioinformatics School of Public Health   (United States)

^c UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^d EMORY UNIVERSITY   (United States)

^e Office of Workforce and Career Development   (United States)

^f NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; BACTEREMIA; CHILD; CONTROLLED STUDY; DISEASE SURVEILLANCE; FATALITY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MENINGITIS; MENINGOCOCCOSIS; MORTALITY; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SOUTH AFRICA;

ADOLESCENT; ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; BACTEREMIA; CHILD; CHILD, PRESCHOOL; FEMALE; HIV INFECTIONS; HUMANS; INCIDENCE; MALE; MENINGITIS, MENINGOCOCCAL; NEISSERIA MENINGITIDIS; RISK FACTORS; SENTINEL SURVEILLANCE; SOUTH AFRICA; YOUNG ADULT;

EID: 77952899442     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e32833a2520     Document Type: Article

References (40)

1. Stephens DS, Greenwood B, Brandtzaeg P. Epidemic meningitis, meningococcaemia, and Neisseria meningitidis. Lancet 2007; 369:2196-2210.
2. Nitta AT, Douglas JM, Arakere G, Ebens JB. Disseminated meningococcal infection in HIV-seropositive patients. AIDS 1993; 7:87-90.
3. Witt DJ, Craven DE, McCabe WR. Bacterial infections in adult patients with the acquired immune deficiency syndrome (AIDS) and AIDS-related complex. Am J Med 1987; 82:900-906.
4. Polsky B, Gold JW, Whimbey E, Dryjanski J, Brown AE, Schiff-man G, Armstrong D. Bacterial pneumonia in patients with the acquired immunodeficiency syndrome. Ann Intern Med 1986; 104:38-41. (Pubitemid 16182770)
5. Couldwell DL. Invasive meningococcal disease and HIV coin-fection. Commun Dis Intell 2001; 25:279-280.
6. Gilks CF, Brindle RJ, Otieno LS, Simani PM, Newnham RS, Bhatt SM, et al. Life-threatening bacteraemia in HIV-1 seropositive adults admitted to hospital in Nairobi, Kenya. Lancet 1990; 336:545-549.
7. Bekondi C, Bernede C, Passone N, Minssart P, Kamalo C, Mbolidi D, Germani Y. Primary and opportunistic pathogens associated with meningitis in adults in Bangui, Central African Republic, in relation to human immunodeficiency virus seros-tatus. Int J Infect Dis 2006; 10:387-395.
8. Morla N, Guibourdenche M, Riou JY. Neisseria spp. and AIDS. J Clin Microbiol 1992; 30:2290-2294.
9. Stephens DS, Hajjeh RA, Baughman WS, Harvey RC, Wenger JD, Farley MM. Sporadic meningococcal disease in adults: results of a 5-year population-based study. Ann Intern Med 1995; 123:937-940.
10. Pearson IC, Baker R, Sullivan AK, Nelson MR, Gazzard BG. Meningococcal infection in patients with the human immunodeficiency virus and acquired immunodeficiency syndrome. Int J STD AIDS 2001; 12:410-411.
11. Brindle R, Simani P, Newnham R, Waiyaki P, Gilks C. No association between meningococcal disease and human immunodeficiency virus in adults in Nairobi, Kenya. Trans R Soc Trop Med Hyg 1991; 85:651.
12. Pinner RW, Onyango F, Perkins BA, Mirza NB, Ngacha DM, Reeves M, et al. Epidemic meningococcal disease in Nairobi, Kenya, 1989. The Kenya/Centers for Disease Control (CDC) Meningitis Study Group. J Infect Dis 1992; 166:359-364.
13. Silber E, Sonnenberg P, Ho KC, Koornhof HJ, Eintracht S, Morris L, Saffer D. Meningitis in a community with a high prevalence of tuberculosis and HIV infection. J Neurol Sci 1999; 162:20-26.
14. Greenwood B. Manson lecture. Meningococcal meningitis in Africa. Trans R Soc Trop Med Hyg 1999; 93:341-353.
15. Rosenstein NE, Perkins BA, Stephens DS, Popovic T, Hughes JM. Meningococcal disease. N Engl J Med 2001; 344:1378-1388.
16. Rosenstein NE, Perkins BA, Stephens DS, Lefkowitz L, Cartter ML, Danila R, et al. The changing epidemiology of meningo-coccal disease in the United States, 1992-1996. J Infect Dis 1999; 180:1894-1901.
17. Stephens DS, Munford RS, Wetzler LM. Meningococcal Infections. In: Kaspar DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL, eds. Harrison's principles of internal medicine. 16 ed. USA: McGraw-Hill Companies Inc., 2005; pp. 849-855.
18. Scholten RJ, Bijlmer HA, Valkenburg HA, Dankert J. Patient and strain characteristics in relation to the outcome of meningo-coccal disease: a multivariate analysis. Epidemiol Infect 1994; 112:115-124.
19. von Gottberg A, du Plessis M, Cohen C, Prentice E, Schrag S, de Gouveia L, et al. Emergence of endemic serogroup W135 meningococcal disease associated with a high mortality rate in South Africa. Clin Infect Dis 2008; 46:377-386.
20. Sotir MJ, Ahrabi-Fard S, Croft DR, Kazmierczak J, Monson TA, Wegner MV, Davis JP. Meningococcal disease incidence and mortality in Wisconsin, 1993-2002. WMJ 2005; 104:38-44.
21. Coulson GB, von Gottberg A, du Plessis M, Smith AM, de Gouveia L, Klugman KP. Meningococcal disease in South Africa, 1999-2002. Emerg Infect Dis 2007; 13:273-281.
22. Day C, Gray A. Health and related indicators. In: South African health review 2005. Durban: Health Systems Trust; 2005. pp. 302.
23. Dorrington R, Johnson L, Bradshaw B, Daniel T. The demographic impact of HIV/AIDS in South Africa. National and Provincial Indicators for 2006. Cape Town: Centre for Actuarial Research, South African Medical Research Council and Actuarial Society of South Africa; 2006.
24. Shisana O, Rehele TM, Simbayi LC, Parker W, Zuma K, Connolly C, et al. South African National HIV Prevalence, HIV incidence, behaviour and communication survey, 2005. Cape Town: HSRC Press; 2005.
25. Crowther P, Cohen C, Govender N, Keddy K, von Gottberg A. Predictors of non reporting to a national laboratory-based surveillance programme. Commun Dis Surveill Bull 2008; 6:1-4.
26. Paterson DL, Ko WC, von Gottberg A, Mohapatra S, Casellas JM, Goossens H, et al. Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum beta-lactamases. Clin Infect Dis 2004; 39:31-37.
27. Baddour LM, Yu VL, Klugman KP, Feldman C, Ortqvist A, Rello J, et al. Combination antibiotic therapy lowers mortality among severely ill patients with pneumococcal bacteremia. Am J Respir Crit Care Med 2004; 170:440-444.
28. Janda WM, Knapp JS. Neisseria and Moraxella catarrhalis. In: Murray PR, Baron EJ, Jorgenson JH, Pfaller MA, Yolken RH, eds. Manual of clinical microbiology, 8 ed. Washington DC: ASM Press, 2003; pp. 585-608.
29. Taha MK. Simultaneous approach for nonculture PCR-based identification and serogroup prediction of Neisseria meningi-tidis. J Clin Microbiol 2000; 38:855-857.
30. du Plessis M, von Gottberg A, Cohen C, de Gouveia L, Klugman KP. Neisseria meningitidis intermediately resistant to penicillin causing invasive disease in South Africa, 2001-2005. J Clin Microbiol 2008; 46:3208-3214.
31. Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing; eighteenth informational supplement. CLSI Document M100-S18. Wayne, PA: CLSI; 2008.
32. Singh E, Cohen C, Govender N, Meiring S. A description of HIV testing strategies at 21 laboratories in South Africa. Commun Dis Surveill Bull 2008; 6:16-17.
33. Glencross D, Scott LE, Jani IV, Barnett D, Janossy G. CD45-assisted PanLeucogating for accurate, cost-effective dual-platform CD4R T-cell enumeration. Cytometry 2002; 50:69-77.
34. Schneider E, Whitmore S, Glynn KM, Dominguez K, Mitsch A, McKenna MT. Revised surveillance case definitions for HIV infection among adults adolescents and children aged <18 months and for HIV infection and AIDS among children aged 18 months to <13 years: United States 2008 MMWR Recomm Rep 2008; 57 (RR-10) 1-12
35. Klugman KP, Madhi SA, Feldman C. HIV and pneumococcal disease. Curr Opin Infect Dis 2007; 20:11-15.
36. Kipp W, Kamugisha J, Rehle T. Meningococcal meningitis and HIV infection: results from a case-control study in western Uganda. AIDS 1992; 6:1557-1558.
37. Bartlett JG, Gallant JE, Conradie FM. Medical management of HIV infection. Durham, North Carolina, USA: TheraSim, Inc; 2008.
38. Apicella MA. Neisseria meningitidis. In: Mandell GL, Bennet JE, Dolin R, eds. Principles and practices of infectious diseases. 6 ed. Philadelphia: Elsevier, 2005; pp. 2498-2513.
39. Zar HJ, Madhi SA. Pneumococcal conjugate vaccine: a health priority. S Afr Med J 2008; 98:463-467.
40. Gandhi NR, Moll AP, Lalloo U, PawinskiR, ZellerK, Moodley P, et al. Successful integration of tuberculosis and HIV treatment in rural South Africa: the Sizonq'oba study. J Acquir Immune Defic Syndr 2009; 50:37-43.